Search results for #AACR2022
And here is the #AACR2022 content: github.com/armish/confere…
#AACR2023 ones are also up now: github.com/armish/confere… Will do this for #AACR2022 next and call it a wrap
Throwback to #AACR2022, here's a poster which @sorger_peter (@harvardmed) and @SantagataLab (@BrighamWomens) teams presented the development of high-performance #cancerbiomarkers using multi-modal #digitalpathology and machine learning algorithms: tinyurl.com/ynt2m6a2
Here's a new one that might be appreciated by @AACR @LauraKalafarski @BrownUCancer stated yesterday after she organized and hosted our cancer center reception in 2022 in New Orleans #AACR2022: @AACR is like a nerdy Mardi Gras #MardiGras (AND) far superior to the original!!…
Exciting news! Miltenyi Biotec is returning to the AACR conference in the beautiful city of Orlando. We can't wait to showcase our latest advancements in cancer research and welcome you to our booth! #AACR2022 #MiltenyiBiotec #CancerResearch #Orlando ow.ly/nMP550N4F1A
5a/ $PVCT. High-risk and refractory adult solid tumor cancers (preclinical) at the annual meeting of the American Association for Cancer Research. #AACR22 #AACR2022. #rosebengal #rosebengalsodium.
Want to see our new & improved poster since presenting at #AACR2022? Come check out Poster Session: Epigenetics and Chromatin Remodeling on Dec 5th 12:15 PM - 3:15 PM at #cellbio2022. I will be at Board Number: B309. Stop by if interested in #cellularsenescence & #cancertherapy!
Extremely grateful that i had the chance to meet Prof @frankpmccormick @UCSF He is one in a million 🦸♂️ #AACR2022 #sorafenibdiscovery
Terrific start into the #aacr2022 early morning with @K_BasenEngquist presenting on exercise in cancer survivors across Texas communities! @Neil_Iyengar @aicrtweets
ASCO and AACR 2022 were big deals for DetermaIO™. Did you listen to the KOL's talk about why? lifesci.rampard.com/WebcastingAppv… #expandingthemarket #ICI #colorectalcancer #TNBC #ASCO2022 #AACR2022 $OCX
@hotirishmonkey @PamSharmaMDPhD @JimAllisonPhD @parkerici @NIBITSIENA Few things compare to late night science talk with @hotirishmonkey! Thinking back 2 #AACR2022 with friends @tcellsrus @JeromeGalon @aruthak @Asthika & others! Great ideas applying big data #AI & #MachineLearning to #Cancer #immunotherapy 2 #FinishCancer /more of this @#SITC2022
A study presented at #AACR2022 reveals that up to 1/4 of cases of #DCIS recur, and ½ of those are invasive breast cancer. wb.md/3fcw5oA. #DCISionRT uses the patient’s tumor biology to provide a 10-year Total and Invasive Recurrence Risk after BCS as well as BCS with RT.
There were five abstracts at ASCO and AACR this year expanding the evidence supporting DetermaIO™. investors.oncocyte.com/news-releases/… #ASCO2022 #AACR2022 #cancer #oncology $OCX
#ICYMI our CEO Mai-Britt Zocca, Ph.D., was recently featured in @Pharmashot discussing our pioneering T-win® Technology platform as well as data presented at #AACR2022 from our Phase I/II clinical trial in metastatic #melanoma. To read more, click here: bit.ly/3vOd3KQ
@NCICancerBio @UW @theNCI @gulleyj1 @sitcancer @hopkinskimmel Q8:A4 A similar combo #immunotherapy trio trial of DPV-001 #cancer #vaccine + anti-PD1 +/-anti-GITR led by Dr @romleidner @ChilesResearch showed tumor go from cold to hot plus #TIM3 & #LAG3 increased in on Tx biopsy/Challenge design trials that build on this knowledge #AACR2022
